Identifying proteins that are only present in bodily fluids when a patient has breast cancer could provide a way to screen healthy people for the disease.
Corporate medicine is hijacking feminist narratives around empowerment and women’s rights to market technologies, tests and treatments that aren’t backed by evidence.
Some states, especially in the Southeastern US, have large disparities in breastfeeding among racial groups, making clear the need to lower barriers for breastfeeding in the workplace and elsewhere.
Being diagnosed with metastatic breast cancer means ongoing treatment to live as long, and as well, as possible. It also creates considerable need for emotional and practical support.
Mammograms are usually analysed by two doctors. But a new study found using one doctor with AI assistance detected 20% more cancers and reduced the workload by 44%.
Alcohol use contributes to over 200 different diseases, injuries, and conditions. It is also a risk factor for gender-based violence and violent crime.
Dense breast tissue is common and normal, but it can make cancer more difficult to detect. FDA requirements going into effect in September 2024 will dictate that patients be better informed about it.
There’s a long history in our society of period pain being played down, or just considered “normal”. But there’s plenty of evidence in the historical records that women have always experienced it.
Services such as chemotherapy are only available in tertiary hospitals located in the country’s urban centres. Transport to these hospitals can be a barrier to care.
Our study found women aren’t necessarily aware of the link between alcohol and breast cancer. And even when they are, they aren’t always able to ‘choose’ to quit.
Professor of Breast Cancer Research, Institute of Health and Biomedical Innovation and School of Biomedical Sciences,, Queensland University of Technology